300009 安科生物
按盤價 
8.520 -0.280 (-3.182%)
8.520 -0.280 (-3.182%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.538 | 16.935 | 17.985 | 24.395 | 23.461 |
| 總資產報酬率 ROA (%) | 6.227 | 13.764 | 14.018 | 18.403 | 17.746 |
| 投入資產回報率 ROIC (%) | 7.343 | 16.560 | 17.522 | 23.685 | 22.864 | 邊際利潤分析 |
| 銷售毛利率 (%) | 75.815 | 75.698 | 77.394 | 78.353 | 78.406 |
| 營業利潤率 (%) | 35.695 | 31.625 | 31.797 | 32.242 | 36.121 |
| 息稅前利潤/營業總收入 (%) | 35.555 | 31.577 | 31.599 | 31.968 | 35.668 |
| 淨利潤/營業總收入 (%) | 30.996 | 28.239 | 28.227 | 29.960 | 31.645 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.874 | 97.325 | 94.034 | 101.666 | 92.447 |
| 價值變動淨收益/利潤總額(%) | 2.705 | 2.411 | 3.232 | -0.560 | 4.929 |
| 營業外收支淨額/利潤總額(%) | -0.385 | -0.456 | -0.421 | -0.440 | -0.977 | 償債能力分析 |
| 流動比率 (X) | 4.026 | 3.744 | 3.408 | 2.745 | 2.827 |
| 速動比率 (X) | 3.515 | 3.349 | 2.963 | 2.468 | 2.516 |
| 資產負債率 (%) | 13.937 | 14.624 | 16.268 | 20.571 | 20.089 |
| 帶息債務/全部投入資本 (%) | -0.429 | -1.639 | -1.573 | -1.701 | -2.329 |
| 股東權益/帶息債務 (%) | -22,567.715 | -5,977.090 | -6,203.621 | -5,718.036 | -4,160.325 |
| 股東權益/負債合計 (%) | 596.213 | 561.818 | 493.686 | 366.977 | 375.201 |
| 利息保障倍數 (X) | -12,655.932 | 329.333 | -488.601 | -240.501 | -347.433 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 66.383 | 57.830 | 70.448 | 59.994 | 64.782 |
| 存貨周轉天數 (天) | 182.189 | 153.942 | 167.191 | 129.323 | 140.078 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
